Skip to main content

FDA recall, , Moderate risk

American Natl. Red Cross Red Blood Cells, Leukocytes Reduced

Red blood cell products, Red Blood Cells, Leukocytes Reduced, and Apheresis Red Blood Cells, Leukocytes Reduced, were distributed with incomplete testing.

American Natl. Red Cross-Greater Chesapeake & Potomac Region began this recall on Jun 4, 2026. FDA posted it on Nov 12, 2026, the day the recall ended.

What happened

The American Natl. Red Cross-Greater Chesapeake & Potomac Region, based in Baltimore, Maryland, started a voluntary recall of Red Blood Cells, Leukocytes Reduced, and Apheresis Red Blood Cells, Leukocytes Reduced. The reason given is that these products were distributed with incomplete testing. The company began the recall on June 4, 2026, and told customers by telephone. The notice names Maryland as the state affected. The FDA classified the recall on November 12, 2026.

What to do

Biologics such as blood, tissue and vaccines are usually given by hospitals and clinics. If you had a transfusion, transplant, infusion or vaccine, ask the place that treated you whether this product was used. If they contact you, follow their advice.

What was recalled

2 products

Hospitals, clinics and blood banks match these details against their records.

  1. Red Blood Cells, Leukocytes Reduced

    Reason: Red Blood Cells, Leukocytes Reduced, with incomplete testing, were distributed.

    Unit number
    • W18532645039900Q
  2. Apheresis Red Blood Cells, Leukocytes Reduced

    Reason: Apheresis Red Blood Cells, Leukocytes Reduced, with incomplete testing, were distributed.

    Unit number
    • W18532645969100M
    • W18532645730500W

Recall details

Posted by FDA
Recall began
Status
Ended Nov 12, 2026
Distributed to

Only in Maryland

Recalled by
American Natl. Red Cross-Greater Chesapeake & Potomac RegionBaltimore, Maryland
Risk

Moderate risk

Its use may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
100029
Recall numbers
B-0014-2027 to B-0015-2027
Recall type
Started by the company
How the company first told customers
Phone

All recalls from American Natl. Red Cross-Greater Chesapeake & Potomac Region

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. American Natl. Red Cross-Greater Chesapeake & Potomac Region began the recall

  2. FDA posted the recall to its Enforcement Report, rated it Class II (moderate risk) and closed it

  3. Added to Recall Canary

Summary by Recall Canary, written with AI · summary updated Nov 14, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab) recall · cite: “American Natl. Red Cross Red Blood Cells, Leukocytes Reduced Recall.” Recall Canary. https://recallcanary.com/recall/fda/american-natl-red-cross-greater-red-blood-cells.